Who Owns NEWAMSTERDAM PHARMA COMPANY (NAMSW)? -- Institutional Holders (2026-06-30)

14 institutions reported holding $45.9M of NEWAMSTERDAM PHARMA COMPANY (NAMSW) in SEC 13F filings for 2026-06-30. Largest institutional holders: Ikarian Capital, LLC ($13.6M), Frazier Life Sciences Management, L.P. ($10.7M), RA CAPITAL MANAGEMENT, L.P. ($7.1M), Affinity Asset Advisors, LLC ($5.3M), Bain Capital Life Sciences Investors, LLC ($2.1M). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1Ikarian Capital, LLC$13.6M400,000New
2Frazier Life Sciences Management, L.P.$10.7M500,333Hold
3RA CAPITAL MANAGEMENT, L.P.$7.1M333,333Hold
4Affinity Asset Advisors, LLC$5.3M245,000Hold
5Bain Capital Life Sciences Investors, LLC$2.1M99,999Hold
6DEERFIELD MANAGEMENT COMPANY, L.P.$2.0M92,787Hold
7MILLENNIUM MANAGEMENT LLC$1.6M75,000Hold
8SIMPLEX TRADING, LLC$1.5M45,400Trimmed
9IMC-Chicago, LLC$1.1M32,700Added
10ARISTEIA CAPITAL, L.L.C.$343,37715,708Hold
11WOLVERINE ASSET MANAGEMENT LLC$318,94714,925Added
12Vestcor Inc$143,0006,666Hold
13GROUP ONE TRADING LLC$16,945500Hold
14UBS Group AG$8,523443Added

Source: SEC Form 13F filings · as of 2026-06-30